Richard Nowak, MD, MS

Richard Nowak, MD, MS, is the director of the Yale Myasthenia Gravis Clinic, where he treats patients with the chronic, autoimmune condition that causes muscles to tire and weaken easily. He provides personalized treatment strategies for patients suffering from myasthenia gravis and other autoimmune neuromuscular conditions.

In addition, Dr. Nowak works with the Yale Medicine Neuromuscular Medicine Program, which is supported by the Muscular Dystrophy Association (MDA), and is a designated MDA-ALS clinic. The program provides comprehensive diagnostic evaluation, consultation and management for a range of neuromuscular disorders.

An associate professor of neurology at Yale School of Medicine, Dr. Nowak is also a busy researcher who directs the Program in Clinical and Translational Neuromuscular Research at Yale, where his goal is to improve the understanding of autoimmune neuromuscular disorders, identify new drug targets and explore new therapies. In 2013, he was awarded a $4.8 million grant to conduct the first clinical trial for myasthenia gravis sponsored by the National Institutes of Health.